Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Davis GL 3rd"'
Autor:
Citrome L, Suett M, Franzenburg KR, Eshet R, Elgart A, Davis GL 3rd, Harary E, Tohami O, Mychaskiw MA, Kane JM
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1901-1917 (2024)
Leslie Citrome,1 Mark Suett,2 Kelli R Franzenburg,3 Roy Eshet,4 Anna Elgart,4 Glen L Davis 3rd,5 Eran Harary,4 Orna Tohami,4 Marko A Mychaskiw,6 John M Kane7– 9 1Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla,
Externí odkaz:
https://doaj.org/article/4c8c119c36ed4df6ad5d5eb1cf734bc6
Autor:
Kane JM; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, 75-59 263rd St, Glen Oaks, NY, 11004, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA., Eshet R; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Harary E; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Tohami O; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Elgart A; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Knebel H; Global Patient Safety and Pharmacovigilance, Teva Pharmaceutical Industries Ltd. , Netanya, Israel., Sharon N; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Suett M; Global Medical Affairs, Teva UK Limited, Harlow, UK., Franzenburg KR; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Davis GL 3rd; Global Clinical Operations, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Correll CU; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, 75-59 263rd St, Glen Oaks, NY, 11004, USA. CCorrell@northwell.edu.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. CCorrell@northwell.edu.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA. CCorrell@northwell.edu.; Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany. CCorrell@northwell.edu.
Publikováno v:
CNS drugs [CNS Drugs] 2024 Aug; Vol. 38 (8), pp. 625-636. Date of Electronic Publication: 2024 Jul 02.
Autor:
Kane JM; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA. Electronic address: jkane2@northwell.edu., Harary E; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Eshet R; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Tohami O; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Weiser M; Sheba Medical Center, Department of Psychiatry, Tel Hashomer, Israel; Sackler School of Medicine at Tel Aviv University, Department of Psychiatry, Tel Aviv, Israel., Leucht S; Technical University of Munich, School of Medicine, Department of Psychiatry and Psychotherapy, Munich, Germany., Merenlender-Wagner A; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Sharon N; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Davis GL 3rd; Teva Branded Pharmaceutical Products R&D, Global Clinical Operations, West Chester, PA, USA., Suett M; Teva UK, Global Medical Affairs, Harlow, UK., Franzenburg KR; Teva Branded Pharmaceutical Products R&D, Global Medical Affairs, West Chester, PA, USA., Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA; Charité-Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.
Publikováno v:
The lancet. Psychiatry [Lancet Psychiatry] 2023 Dec; Vol. 10 (12), pp. 934-943. Date of Electronic Publication: 2023 Nov 02.